Further Tylenol recall for J&J

Published: 29 Jun 2011

Johnson & Johnson's McNeil Consumer Healthcare division has announced the voluntary recall of one product lot of Tylenol extra strength caplets in the US following reports of a 'mouldy odour'.

Around 60,000 bottles are affected, with the unusual smell linked to trace amounts of a chemical known as 2,4,6-tribromoanisole (TBA), a by-product of a chemical preservative sometimes applied to wood often used in the construction of pallets on which materials are transported.

Earlier this month, J&J's Ortho-McNeil-Janssen subsidiary voluntarily recalled one unit each of schizophrenia drugs Risperdal and risperidone for a similar reason.

J&J said: "This voluntary action is being taken as a precaution and the risk of serious adverse medical events is remote. TBA can generate an offensive odour and has been associated with temporary and non-serious gastrointestinal symptoms."

It is recommend that consumers who have purchased the product from the lot number (ABA619 ) stop using the drug and contact McNeil Consumer Healthcare for further information.

The latest announcement follows several Tylenol recalls by McNeil Consumer Healthcare since May 2010.

Published: 29 Jun 2011

Comments are moderated and will not appear until approved by a member of the Communique team.